Two Sigma Securities’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
10,338
+8,425
+440% +$1.02M 0.1% 259
2026
Q1
$313K Buy
+1,913
New +$294K 0.04% 747
2025
Q3
– Sell
-11,414
Closed -$1.15M – 1694
2025
Q2
$1.15M Buy
+11,414
New +$873K 0.14% 176
2024
Q3
– Sell
-3,798
Closed -$254K – 3224
2024
Q2
$254K Buy
+3,798
New +$147K ﹤0.01% 2146
2020
Q1
– Sell
-12,060
Closed -$288K – 1814
2019
Q4
$288K Buy
+12,060
New +$245K ﹤0.01% 1819
2017
Q4
– Sell
-16,412
Closed -$512K – 1864
2017
Q3
$512K Buy
+16,412
New +$313K 0.05% 262

Other funds holding INSM

Two Sigma Securities's INSM Position: Q2 2026 in Review

Two Sigma Securities increased its Insmed (INSM) stake by 440% in Q2 2026, buying an estimated $1.02M and bringing the position to 10,338 shares worth $1.1M. The position accounts for 0.1% of the portfolio, ranked #259.

Two Sigma Securities first reported a position in INSM in Q3 2017 and has held it in 6 quarters since. The position peaked at $1.15M in Q2 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Two Sigma Securities held 10,338 shares of Insmed worth $1.1M as of Q2 2026.
  • Two Sigma Securities bought 8,425 Insmed shares in Q2 2026, an estimated $1.02M.
  • Insmed made up 0.1% of Two Sigma Securities's portfolio in Q2 2026, its #259 holding.
  • Two Sigma Securities first reported a position in Insmed in Q3 2017 and has held it in 6 quarters since.
  • Two Sigma Securities's Insmed position peaked at $1.15M in Q2 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.